Matt Larew
Stock Analyst at William Blair
(0)
# 5080
Out of 5,218 analysts
16
Total ratings
28.57%
Success rate
-48.74%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Maravai LifeSciences | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Nov 8, 2024 | |
Amedisys | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Jul 1, 2024 | |
Ginkgo Bioworks Hold... | Downgrades: Underperform | n/a | n/a | n/a | 3 | May 10, 2024 | |
AptarGroup | Upgrades: Outperform | n/a | n/a | n/a | 1 | Apr 29, 2024 | |
Bio-Techne | Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Sep 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | n/a | n/a | n/a | 1 | Jun 29, 2021 |